{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:59:33Z","timestamp":1785499173606,"version":"3.56.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"DOI":"10.7759\/cureus.113716","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:26:01Z","timestamp":1785497161000},"source":"Crossref","is-referenced-by-count":0,"title":["Acquired Hemophilia A in an Elderly Patient Receiving Clopidogrel: Drug-Induced or Age-Associated Autoimmunity?"],"prefix":"10.7759","author":[{"given":"Akhil","family":"Mohanachandran Pushpaleela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahil Omar","family":"Tai Valappil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayshath","family":"Hansiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation","volume":"109","author":"Collins PW","year":"2007","unstructured":"Collins PW, Hirsch S, Baglin TP, et al.. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood. 2007, 109:1870-1877. 10.1182\/blood-2006-06-029850","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"Knoebl P","year":"2012","unstructured":"Knoebl P, Marco P, Baudo F, et al.. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012, 10:622-631. 10.1111\/j.1538-7836.2012.04654.x","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-143586","article-title":"Acquired factor VIII inhibitors","volume":"112","author":"Franchini M","year":"2008","unstructured":"Franchini M, Lippi G. Acquired factor VIII inhibitors. Blood. 2008, 112:250-255. 10.1182\/blood-2008-03-143586","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres R","year":"2017","unstructured":"Kruse-Jarres R, Kempton CL, Baudo F, et al.. Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol. 2017, 92:695-705. 10.1002\/ajh.24777","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-011-2258-5","article-title":"Acquired hemophilia: a rare but life-threatening potential cause of bleeding in the intensive care unit","volume":"37","author":"Shander A","year":"2011","unstructured":"Shander A, Walsh CE, Cromwell C. Acquired hemophilia: a rare but life-threatening potential cause of bleeding in the intensive care unit. Intensive Care Med. 2011, 37:1240-1249. 10.1007\/s00134-011-2258-5","journal-title":"Intensive Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04309.x","article-title":"Management of acquired haemophilia A","volume":"9","author":"Collins PW","year":"2011","unstructured":"Collins PW. Management of acquired haemophilia A. J Thromb Haemost. 2011, 9:226-235. 10.1111\/j.1538-7836.2011.04309.x","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-408930","article-title":"Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry","volume":"120","author":"Baudo F","year":"2012","unstructured":"Baudo F, Collins P, Huth-K\u00fchne A, et al.. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood. 2012, 120:39-46. 10.1182\/blood-2012-02-408930","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.001743","article-title":"International recommendations on the diagnosis and treatment of patients with acquired hemophilia A","volume":"94","author":"Huth-K\u00fchne A","year":"2009","unstructured":"Huth-K\u00fchne A, Baudo F, Collins P, et al.. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica. 2009, 94:566-575. 10.3324\/haematol.2008.001743","journal-title":"Haematologica"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1684\/abc.2024.1900","article-title":"[Acquired hemophilia A and emicizumab for the treatment of bleeding: two case report and a literature review]","volume":"82","author":"Launois A","year":"2024","unstructured":"Launois A, Martin-Toutain I, Devaux F, et al.. [Acquired hemophilia A and emicizumab for the treatment of bleeding: two case report and a literature review]. Ann Biol Clin (Paris). 2024, 82:294-307. 10.1684\/abc.2024.1900","journal-title":"Ann Biol Clin (Paris)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.282099","article-title":"Emicizumab: the hemophilia A game-changer","volume":"109","author":"Alcedo Andrade PE","year":"2024","unstructured":"Alcedo Andrade PE, Mannucci PM, Kessler CM. Emicizumab: the hemophilia A game-changer. Haematologica. 2024, 109:1334-1347. 10.3324\/haematol.2022.282099","journal-title":"Haematologica"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14692","article-title":"Drug-associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance database","volume":"29","author":"Konstantinov K","year":"2023","unstructured":"Konstantinov K, Dolladille C, Gillet B, Alexandre J, Aouba A, Deshayes S, Repesse Y. Drug-associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance database. Haemophilia. 2023, 29:186-192. 10.1111\/hae.14692","journal-title":"Haemophilia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/500678-acquired-hemophilia-a-in-an-elderly-patient-receiving-clopidogrel-drug-induced-or-age-associated-autoimmunity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:26:02Z","timestamp":1785497162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/500678-acquired-hemophilia-a-in-an-elderly-patient-receiving-clopidogrel-drug-induced-or-age-associated-autoimmunity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.113716","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}